Kyverna Therapeutics Inc.
(KYTX)
undefined
undefined%
At close: undefined
Ratios (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 |
PE Ratio | -83.69 | -6.70 | -7.34 |
PS Ratio | 0.00 | 27.55 | 34.22 |
PB Ratio | 102.73 | -2.62 | -4.18 |
P/FCF Ratio | -95.27 | -5.25 | -8.25 |
P/OCF Ratio | -96.40 | -5.36 | -8.74 |
OCF/S Ratio | 0.00 | -1.29 | -0.98 |
Debt / Equity Ratio | 0.01 | 0.00 | 0.00 |
Quick Ratio | 0.76 | 1.11 | 1.21 |
Current Ratio | 0.76 | 1.11 | 1.21 |
Asset Turnover | 0.00 | 0.10 | 0.07 |
Interest Coverage | -83.43 | -113.02 | -2195.50 |
Return on Equity (ROE) | -122.75% | 39.05% | 56.97% |
Return on Assets (ROA) | -80.28% | -43.17% | -30.82% |
Return on Capital (ROIC) | -112.78% | -53.45% | -37.88% |
Dividend Yield | 0.00% | 0.00% | 0.00% |
Payout Ratio | 0.00% | 0.00% | 0.00% |
Gross Profit Margin | 0.00% | 21.26% | 22.41% |
Net Profit Margin | 0.00% | -102.82% | -116.47% |